Value of select contract pharma manufacturing companies 2022
This statistic depicts the total enterprise value of select contract development and manufacturing companies, as of December 31, 2022. At this point, Catalent Inc. had a total enterprise value of some 8.1 billion U.S. dollars. A contract development and manufacturing organization (CDMO) is able to take over some parts of a pharmaceutical company, which could include any service from drug development to drug manufacturing.